Global Cardiac Rhythm Management Devices Market is expected to reach USD XXmillion by 2022. Cardiac Rhythm Management Devices helps in the treatment of abnormal heart conditions by the use of pacemakers and implantable cardioverter defibrillators (ICDs). These devices revenue is expected to reach USD XXmillion annually by 2022 with compound annual growth rate of XX%. North America shows the maximum growth of Cardiac Rhythm Management Devices with a market share of XX% whereas Europe accounts for XX% of the market share. The maximum growth of Cardiac Rhythm Management Devices is being generated from the Pacemakers market.
Cardiac Rhythm Management Devices market is driven by new technology innovations and aging population. These devices have become less invasive and significant advances in pacing and pulse generator technology have enabled effective long-term device therapy with limited complications.
Some of the factors that are driving the market for cardiac rhythm management devices is the high global prevalence of cardiac arrhythmias, increasing cases of lifestyle habits such as smoking, excessive alcohol consumption and obesity, which makes a person more susceptible to cardiac arrhythmias and rising patient awareness levels will also drive the growth of this market.
Lack of awareness about sudden cardiac arrests, high cost of the devices, dearth of skilled healthcare professionals and therapeutic radiation is hindering the growth of the global cardiac rhythm management market.
The global cardiac rhythm management devices market has been segmented based on the product type as cardiac defibrillators, cardiac pacemakers, cardiac resynchronization therapy and cardiovascular pacing leads. The market has also been segmented based on geography as North America, Europe, Asia-Pacific, Middle East and Africa, and South America
Some of the key players in this market include –
Medtronic is the market leader in the Cardiac Rhythm Management market. Some other major players on the market include Biotronik SE & Co. KG, Boston Transtec LLC, Cardialen INC., CVRX Inc., DHS medical, EBR systems inc., Endurance rhythm inc. and many more.
Market definition for the cardiac assist devices market, along with identification of key drivers and restraints for the market.
Market analysis for the cardiac assist devices market, with region-specific assessments and competition analysis on a global and regional scale.
Identification of factors instrumental in changing the market scenario, rising prospective opportunities and identification of key companies that can influence the market on a global and regional scale.
Extensively researched competitive landscape section with profiles of major companies along with their strategic initiatives and market share.
Identification and analysis of the macro and micro factors that affect the global cardiac rhythm management devices market on both global and regional scale.
Coverage of Major Players includes company profiles, financials and major products and services.